NINDS Primary Lateral Sclerosis Information Page

Skip secondary menu

Table of Contents (click to jump to sections)


What is Primary Lateral Sclerosis?

Primary lateral sclerosis (PLS) is a rare neuromuscular disease with slowly progressive weakness in voluntary muscle movement. PLS belongs to a group of disorders known as motor neuron diseases. In motor neuron diseases, the nerve cells that control voluntary muscle movement degenerate and die. In PLS, the corticospinal motor neurons (often called "upper motor neurons") in the brain are affected. There is no evidence of degeneration of lower motor neurons in the spinal cord or brainstem and there is little muscle wasting (what doctors call "amyotrophy"). Symptoms include weakness, muscle stiffness and spasms (spasticity), clumsiness, slowing of movement, and problems with balance. Onset of PLS usually occurs after age 40. The symptoms often begin with problems in the legs, but may also start with hand clumsiness or changes in speech. PLS progresses gradually over a number of years, or even decades. Scientists do not believe PLS has a simple hereditary cause. There are similar, but rare, hereditary childhood disorders termed "juvenile PLS." The diagnosis of PLS requires extensive testing to exclude other diseases. When symptoms begin, PLS may be mistaken for amyotrophic lateral sclerosis or ALS (Lou Gehrig's disease) and the diagnosis of PLS can be delayed for several years.

Is there any treatment?

Treatment for individuals with PLS is symptomatic. Baclofen and tizanidine may reduce spasticity. Quinine or phenytoin may decrease cramps. Physical therapy helps prevent joint immobility and maintain muscle strength. Speech therapy may be useful for those with involvement of the facial muscles.

What is the prognosis?

PLS is not fatal. There is no cure and the progression of symptoms varies. Some people may retain the ability to walk without assistance, but others eventually require wheelchairs, canes, or other assistive devices.

What research is being done?

The NINDS conducts a broad range of research on neuromuscular disorders such as PLS. This research is aimed at developing techniques to diagnose, treat, prevent, and ultimately cure these devastating diseases.

NIH Patient Recruitment for Primary Lateral Sclerosis Clinical Trials

Organizations

Spastic Paraplegia Foundation
Spastic Paraplegia Foundation PO Box 1208 Fortson, GA 31808 Phone: 877-773-4483 Email: information@sp-foundation.org www.sp-foundation.org
Suite 123
Falls Church, VA   22043
information@sp-foundation.org
http://www.sp-foundation.org
Tel: 1-877-SPF-GIVE (1-877-773-4483)
Fax: 877-SPF-GIVE

ALS Association
27001 Agoura Road
Suite 150
Calabasas Hills, CA   91301-5104
advocacy@alsa-national.org
http://www.alsa.org
Tel: 818-880-9007 800-782-4747
Fax: 818-880-9006

Synapse: A PLS Newsletter
212 Farm Road
Sherborn, MA   01770
synapsePLS@comcast.net
http://synapsepls.org
Tel: 508-653-5246

 


Prepared by:
Office of Communications and Public Liaison
National Institute of Neurological Disorders and Stroke
National Institutes of Health
Bethesda, MD 20892



NINDS health-related material is provided for information purposes only and does not necessarily represent endorsement by or an official position of the National Institute of Neurological Disorders and Stroke or any other Federal agency. Advice on the treatment or care of an individual patient should be obtained through consultation with a physician who has examined that patient or is familiar with that patient's medical history.

All NINDS-prepared information is in the public domain and may be freely copied. Credit to the NINDS or the NIH is appreciated.

Last updated March 12, 2009